Evidence mapPaperPMID 42397502Full record

ArticleOphthalmology and therapy2026

Identification of OCTA Biomarkers and Cutoff Values Associated with Disease Severity in Dry Age-Related Macular Degeneration.

Bogdan Dugiełło, Katarzyna Bujała, Bartłomiej Bolek, Adam Wylęgała, Edward Wylęgała

Abstract read
In one paragraph

Article in Ophthalmology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bogdan DugiełłoChair and Clinical Department of Ophthalmology, School of Medicine in Zabrze, Medical University of Silesia in Katowice, District Railway Hospital, 40-760, Katowice, Poland. bogdan.dugiello@gmail.com.ORCID http://orcid.org/0000-0001-8119-0245
Katarzyna BujałaChair and Clinical Department of Ophthalmology, School of Medicine in Zabrze, Medical University of Silesia in Katowice, District Railway Hospital, 40-760, Katowice, Poland.
Bartłomiej BolekChair and Clinical Department of Ophthalmology, School of Medicine in Zabrze, Medical University of Silesia in Katowice, District Railway Hospital, 40-760, Katowice, Poland.
Adam WylęgałaChair and Clinical Department of Ophthalmology, School of Medicine in Zabrze, Medical University of Silesia in Katowice, District Railway Hospital, 40-760, Katowice, Poland.
Edward WylęgałaChair and Clinical Department of Ophthalmology, School of Medicine in Zabrze, Medical University of Silesia in Katowice, District Railway Hospital, 40-760, Katowice, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOptical coherence tomography angiography (OCTA) enables noninvasive assessment of retinal and choroidal microvasculature and may provide quantitative biomarkers of disease severity in dry age-related macular degeneration (AMD). This study aimed to identify OCTA-derived vascular parameters associated with consecutive stages of dry AMD and determine cutoff values for stage differentiation.

methodsThis cross-sectional study included 182 eyes of 123 participants. Eyes were classified according to the Beckman classification into control, early, intermediate, and late dry AMD groups. OCTA imaging was performed using the ZEISS PLEX Elite 9000 swept-source OCTA system. Quantitative analysis of the superficial capillary plexus (SCP), deep capillary plexus (DCP), and choriocapillaris (CC) was conducted using AngioTool software. Vessel density, vessel length, junction-related parameters, endpoints, and lacunarity were analyzed. Group comparisons were performed using analysis of variance (ANOVA) or the Kruskal-Wallis test with post hoc analysis. Receiver operating characteristic (ROC) curves were used to evaluate diagnostic performance and determine optimal cutoff values.

resultsIn the SCP, vessel density decreased from 43.83 ± 2.08% in controls to 41.27 ± 3.96% in intermediate AMD (p < 0.001), and mean lacunarity increased from 0.05 ± 0.01 to 0.07 ± 0.03 (p < 0.001), while other parameters showed no significant differences. In the DCP, vessel density declined from 51.71 ± 2.38% in controls to 48.73 ± 4.66% and 43.80 ± 4.98% across disease stages (p < 0.001), with total vessel length decreasing from 73.32 ± 2.72 to 61.58 ± 6.69 (p < 0.001), indicating progressive vascular simplification. The most pronounced changes were observed in the choriocapillaris, where vessel density decreased from 63.28 ± 0.94 to 60.31 ± 1.83% and 26.62 ± 22.30% (p < 0.001), and total vessel length from 102.80 ± 2.24 to 35.68 ± 38.42 (p < 0.001). ROC analysis identified SCP mean lacunarity (cutoff 0.0575, AUC 0.76) as a marker of early disease. In the DCP, total number of junctions below 254 and total vessel length below 66.10 were associated with advanced disease. The highest diagnostic performance was observed for choriocapillaris parameters, including vessel density below 57.38 and total vessel length below 91.10, with sensitivity exceeding 94% and specificity above 80%.

conclusionOCTA-derived microvascular parameters demonstrate layer-specific alterations in dry AMD. Mean lacunarity in the SCP appeared to be the most sensitive marker of early changes, whereas reductions in junction density and total vessel length in the DCP reflected progressive vascular simplification. The strongest association with disease severity was observed in the choriocapillaris, particularly for vessel density and total vessel length. The identified cutoff values for DCP and CC parameters were associated with different stages of dry AMD and may support stage differentiation and quantitative assessment of disease severity in clinical settings.

Indexed as

Age-related macular degenerationBiomarkersChoriocapillarisDeep capillary plexusOCTARetinal microvasculatureROC analysisSuperficial capillary plexus

Identifiers

PMID42397502
PMCPMC13424041

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.